We are live on ! Find out more
PCM

Pinz Capital Management Portfolio holdings

AUM $55.2M
1-Year Est. Return 15.31%
This Fund
S&P 500
This Quarter Est. Return
+16.64%
1 Year Est. Return
-15.31%
3 Year Est. Return
+198.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
+$56M
Cap. Flow
+$46.5M
Cap. Flow %
16.94%
Top 10 Hldgs %
27.54%
Holding
209
New
98
Increased
10
Reduced
3
Closed
98

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$10M
2
SNOW icon
Snowflake
SNOW
+$8.15M
3
ICE icon
Intercontinental Exchange
ICE
+$7.39M
4
PPD
PPD, Inc. Common Stock
PPD
+$6.45M
5
CHWY icon
Chewy
CHWY
+$6.45M

Top Sells

Rank Stock Value
1
NBIS
Nebius Group N.V.
NBIS
+$5.57M
2
TMUS icon
T-Mobile US
TMUS
+$5.41M
3
ONEM
1Life Healthcare
ONEM
+$5.26M
4
FOXF icon
Fox Factory Holding Corp
FOXF
+$3.66M
5
RPRX icon
Royalty Pharma
RPRX
+$3.64M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Technology 20.86%
3 Consumer Discretionary 16.7%
4 Real Estate 8.36%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVH icon
151
Invitation Homes
INVH
$18B
– –
-96,100
Closed -$2.65M
IOVA icon
152
Iovance Biotherapeutics
IOVA
$2.87B
– –
-39,200
Closed -$1.08M
IR icon
153
Ingersoll Rand
IR
$33.7B
– –
-55,700
Closed -$1.57M
KRYS icon
154
Krystal Biotech
KRYS
$9.66B
– –
-18,600
Closed -$770K
KTOS icon
155
Kratos Defense & Security Solutions
KTOS
$11.4B
– –
-189,700
Closed -$2.96M
LEGN icon
156
Legend Biotech
LEGN
$4.01B
– –
-30,000
Closed -$1.28M
MLAB icon
157
Mesa Laboratories
MLAB
$574M
– –
-7,600
Closed -$1.65M
MRSN
158
DELISTED
Mersana Therapeutics
MRSN
– –
-2,420
Closed -$1.42M
NMIH icon
159
NMI Holdings
NMIH
$3.36B
– –
-129,200
Closed -$2.08M
NTLA icon
160
Intellia Therapeutics
NTLA
$1.67B
– –
-61,950
Closed -$1.3M
OKE icon
161
Oneok
OKE
$54.5B
– –
-103,500
Closed -$3.44M
OSUR icon
162
OraSure Technologies
OSUR
$279M
– –
-168,300
Closed -$1.96M
PCG icon
163
PG&E
PCG
$38.5B
– –
-399,100
Closed -$3.54M
PCVX icon
164
Vaxcyte
PCVX
$8.64B
– –
-20,000
Closed -$632K
PLRX icon
165
Pliant Therapeutics
PLRX
$65M
– –
-500
Closed -$16K
RCUS icon
166
Arcus Biosciences
RCUS
$3.64B
– –
-63,500
Closed -$1.57M
REGN icon
167
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-2,500
Closed -$1.56M
REPL icon
168
Replimune Group
REPL
$1.01B
– –
-51,498
Closed -$1.28M
RGA icon
169
Reinsurance Group of America
RGA
$16.1B
– –
-12,450
Closed -$977K
RNAM
170
DELISTED
Avidity Biosciences
RNAM
– –
-50,000
Closed -$1.41M
RNR icon
171
RenaissanceRe
RNR
$13.4B
– –
-6,300
Closed -$1.08M
ROAD icon
172
Construction Partners
ROAD
$6.77B
– –
-155,838
Closed -$2.77M
RPRX icon
173
Royalty Pharma
RPRX
$25.3B
– –
-75,000
Closed -$3.64M
RPTX
174
DELISTED
Repare Therapeutics
RPTX
– –
-29,800
Closed -$924K
SITM icon
175
SiTime
SITM
$21.8B
– –
-35,800
Closed -$1.7M
5 6
7
8 9

Similar funds

FC
Foundation Capital Palo Alto, California $55.5M AUM 83.75% 1-Year Est. Return
DTIM
Danda Trouve Investment Management Prairie Village, Kansas $54.1M AUM 13.18% 1-Year Est. Return
NHSP
NewView HMS SPV Partners Burlingame, California $53.9M AUM
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
AEPIP
AH Equity Partners III (Parallel) Menlo Park, California $57.6M AUM 72.84% 1-Year Est. Return
SAM
Strategic Asset Management Rochester, Minnesota $57.7M AUM 14.07% 1-Year Est. Return
BI
Blooom Inc Overland Park, Kansas $52.7M AUM 6.26% 1-Year Est. Return
MCAI
Meritech Capital Associates IV Palo Alto, California $51.9M AUM 64.09% 1-Year Est. Return

Pinz Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Pinz Capital Management held 209 positions worth $274M, up 26% from $218M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Pinz Capital Management deployed $46.5M of net new capital in Q3 2020, opening 98 new positions and adding to 10 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 66,500 shares worth $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was 1Life Healthcare, an estimated $5.26M trimmed.

  • Pinz Capital Management's largest Q3 2020 buy was iShares Russell 2000 ETF: 66,500 shares worth $9.96M.
  • Pinz Capital Management added most to Repay Holdings in Q3 2020, an estimated $4.69M increase.
  • Pinz Capital Management's biggest Q3 2020 reduction was 1Life Healthcare, cutting an estimated $5.26M.
  • Pinz Capital Management fully exited Nebius Group N.V. in Q3 2020, selling an estimated $5.57M.
  • Pinz Capital Management's ten largest holdings make up 28% of its $274M portfolio in Q3 2020.
  • Pinz Capital Management opened 98 new positions and closed 98 in Q3 2020.
  • Pinz Capital Management's portfolio value rose 26% quarter-over-quarter to $274M.

Based on Pinz Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.